Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
SWX:NOVN
Novartis
|
93.37 | 8.15% | 21.52% | 190,512.74 | 3.53% | 4.67% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.59 | -11.18% | -1.66% | 17,751.4 | 1.37% | 4.24% |
|
NasdaqGS:HOLX
Hologic
|
75.02 | -20.28% | -13.57% | 17,507.94 | 0% | 12.17% |
|
NYSE:DGX
Quest Diagnostics
|
144.34 | -10.75% | -2.08% | 16,034.96 | 2.08% | 6.66% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29.25% | 11,046.73 | 0.86% | 7.46% |
|
NasdaqGS:NTRA
Natera
|
106.46 | 0% | 0% | 11,680.18 | 0% | 0% |
|
NasdaqCM:EXAS
Exact Sciences
|
50.38 | 0% | 0% | 9,955.48 | 0% | 0% |
|
NYSE:QGEN
QIAGEN N.V.
|
45.69 | 5.93% | 16.33% | 9,668.09 | 0% | 9.09% |
|
ASX:SHL
Sonic Healthcare
|
26.63 | 6.42% | 29.07% | 12,778.75 | 3.91% | 5.68% |
|
NasdaqGS:GH
Guardant Health
|
25.36 | 0% | 0% | 2,369.45 | 0% | 0% |
|
NasdaqCM:NEO
NeoGenomics
|
14.80 | -,131.68% | -58.73% | 1,953.99 | 0% | 0% |
|
NasdaqGS:MYGN
Myriad Genetics
|
25.29 | -,100.21% | -86.68% | 1,789.66 | 0% | 0% |
|
NasdaqGS:OPK
OPKO Health
|
1.01 | 0% | 0% | 1,182.78 | 0% | -,200% |
|
NasdaqGM:CDNA
CareDx, Inc
|
15.50 | -,644.15% | -,406.53% | 575.21 | 0% | 0% |
|
NasdaqGS:VNET
VNET Group
|
2.05 | 0% | 0% | 531.69 | 0% | 0% |
|
NasdaqCM:CRDF
Cardiff Oncology
|
3.63 | 0% | 0% | 154.7 | 0% | 0% |
|
NZSE:PEB
Pacific Edge
|
0.10 | 0% | 0% | 75.45 | 0% | 0% |
|
NasdaqCM:OCX
OncoCyte
|
2.93 | 0% | 0% | 39.16 | 0% | 0% |
|
NasdaqCM:AXDX
Accelerate Diagnostics
|
0.88 | 0% | 0% | 19.07 | 0% | 0% |
|
NasdaqCM:DMTK
DermTech
|
0.50 | 0% | 0% | 17.29 | 0% | 0% |
